Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha-1 Antitrypsin Deficiency (AATD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04157049
What this trial is testing

Alpha-1 Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Alpha-1 Foundation 5,000
Not applicableEnded earlyNCT01241942
What this trial is testing

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 11
Post-approval studies (Phase 4)Study completedNCT01651351
What this trial is testing

GLASSIA Infusion Rate Study

Who this might be right for
Alpha1-antitrypsin DeficiencyHealthy Volunteers
Baxalta now part of Shire 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06405633
What this trial is testing

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Wave Life Sciences USA, Inc. 24
Early research (Phase 1)Study completedNCT00242385
What this trial is testing

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Baxalta now part of Shire 25
Testing effectiveness (Phase 2)Study completedNCT00161707
What this trial is testing

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 40
Not applicableEnded earlyNCT03823443
What this trial is testing

COPD Exacerbation Blood and Urine Biomarkers Study

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAcute Exacerbation CopdAlpha-1 Anti-trypsin Deficiency
Columbia University 7
Early research (Phase 1)Ended earlyNCT02503683
What this trial is testing

An Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease

Who this might be right for
Antitrypsin Deficiency Liver Disease
Alnylam Pharmaceuticals 26
Early research (Phase 1)Ended earlyNCT01183468
What this trial is testing

A Research Trial of Aralast in New Onset Diabetes (RETAIN)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Study completedNCT00430768
What this trial is testing

Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
University of Massachusetts, Worcester 9
Not applicableUnknownNCT02929940
What this trial is testing

Liver Disease in Patients With alpha1-antitrypsin Deficiency

Who this might be right for
alpha1-antitrypsin Deficiency
RWTH Aachen University 500
Early research (Phase 1)Study completedNCT04174118
What this trial is testing

Study of DCR-A1AT in Healthy Adult Volunteers

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 30
Early research (Phase 1)Looking for participantsNCT06996756
What this trial is testing

Gene Therapy for Alpha 1- Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Weill Medical College of Cornell University 16
Not applicableStudy completedNCT03039335
What this trial is testing

The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Biocerna LLC 43
Not applicableStudy completedNCT00532805
What this trial is testing

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Medical University of South Carolina 49
Early research (Phase 1)Ended earlyNCT04443192
What this trial is testing

A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects

Who this might be right for
Alpha1 Anti-Trypsin Deficiency
Z Factor Limited 69
Large-scale testing (Phase 3)Looking for participantsNCT06165341
What this trial is testing

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

Who this might be right for
Alpha1-Antitrypsin Deficiency
Takeda 50
Testing effectiveness (Phase 2)Looking for participantsNCT06389877
What this trial is testing

Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Beam Therapeutics Inc. 106
Large-scale testing (Phase 3)Study completedNCT00295061
What this trial is testing

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Grifols Therapeutics LLC 24
Not applicableStudy completedNCT04262284
What this trial is testing

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

Who this might be right for
Alpha-1 Antitrypsin Deficiency
CSL Behring 15
Next Page